130 related articles for article (PubMed ID: 1360945)
1. Histamine-2 receptor antagonists.
Kumar P; Yachha SK; Misra S; Mehta S
Indian Pediatr; 1992 Aug; 29(8):1019-23. PubMed ID: 1360945
[No Abstract] [Full Text] [Related]
2. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?
Ellis KK; Oehlke M; Helfand M; Lieberman D
Am J Gastroenterol; 1997 Sep; 92(9):1472-4. PubMed ID: 9317065
[TBL] [Abstract][Full Text] [Related]
3. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
Gabryelewicz A; Sarosiek J; Laszewicz W
Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
[No Abstract] [Full Text] [Related]
4. Peptic disease in paediatric patients: a diagnostic and therapeutic contribution.
Deganello A; Tamassia G; Gaburro D
Drugs Exp Clin Res; 1990; 16(2):75-83. PubMed ID: 2401189
[TBL] [Abstract][Full Text] [Related]
5. [The effect of histamine H2 receptor blockaders on the proteolytic activity in patients with ulcers].
Bashir BM
Lab Delo; 1990; (4):25-7. PubMed ID: 1695268
[TBL] [Abstract][Full Text] [Related]
6. [The use of raniberl in the combined treatment of peptic ulcer patients].
Kharchenko NV; Rodonezhskaia EV; Zagoruĭko ZhV
Lik Sprava; 1997; (5):127-30. PubMed ID: 9491719
[No Abstract] [Full Text] [Related]
7. Duodenitis and ulcer relapse.
Prichard PJ; Kerr GD
Lancet; 1985 Jul; 2(8446):102. PubMed ID: 2861516
[No Abstract] [Full Text] [Related]
8. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
9. Duodenitis and ulcer relapse.
Lee FI
Lancet; 1985 Aug; 2(8449):277. PubMed ID: 2862449
[No Abstract] [Full Text] [Related]
10. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
11. Pharmacological control of human gastric acid secretion.
Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():21-5. PubMed ID: 2890148
[No Abstract] [Full Text] [Related]
12. Non-ulcer dyspepsia.
Lagarde SP; Spiro HM
Clin Gastroenterol; 1984 May; 13(2):437-46. PubMed ID: 6146416
[No Abstract] [Full Text] [Related]
13. [Nocturnal gastric secretion and duodenal ulcer].
Mazure RM; Mazure PA
Acta Gastroenterol Latinoam; 1984; 14(3):243-8. PubMed ID: 6152644
[No Abstract] [Full Text] [Related]
14. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
15. Is it "no acid, no ulcer" or "yes acid, worse ulcer"?
Geller A; Gostout CJ
Am J Gastroenterol; 1994 Apr; 89(4):634-5. PubMed ID: 7908499
[No Abstract] [Full Text] [Related]
16. The effect of H2-receptor antagonists on pepsin secretion in man.
Gledhill T; Hunt RH
Prog Clin Biol Res; 1985; 173():159-67. PubMed ID: 2858865
[No Abstract] [Full Text] [Related]
17. Famotidine (Pepcid).
Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
[No Abstract] [Full Text] [Related]
18. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
Vallot T; Mignon M
Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
[No Abstract] [Full Text] [Related]
19. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
[No Abstract] [Full Text] [Related]
20. Famotidine in the USA: a review of efficacy studies.
Gitnick G
J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
